HLA-DRB1 and myeloid sarcoma: Using four-digit high-resolution genotyping, our findings highlighted the presence of DRB1*15:01 among 8.8% of the Moroccan MS population vs. 4.08% in healthy controls (p = 0.12), while the risk of developing MS was 2.18.